Pregled po CROSBI profilu: Vlatko Pejša (CROSBI Profil: 16491, MBZ: 221244)
Pronađeno 134 radova
-
1.(KroHem) Mitrović, Zdravko; Dujmović, Dino; Jakšić, Ozren; Bašić-Kinda, Sandra; Gaćina, Petar; Periša, Vlatka; Prka, Željko; Dreta, Barbara; Galušić Davor; Holik, Hrvoje et al.Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7 doi:10.1111/ejh.13957 (međunarodna recenzija, članak, znanstveni)
-
2.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kovačević, Stjepan; Atić, Armin; Pejša, Vlatko; Kušec, RajkoBaseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes // Leukemia & lymphoma, 63 (2022), 7; 1556-1565 doi:10.1080/10428194.2022.2034160 (međunarodna recenzija, članak, znanstveni)
-
3.Sabljić, Anica; Sedinić Lacko, Martina; Kušec, Rajko; Pejša, Vlatko; Lucijanić, MarkoNo Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA- EPOCH // Pharmacology, 107 (2022), 11-12; 623-627 doi:10.1159/000526625 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
4.Galušić, Davor; Bašić-Kinda, Sandra; Pijuk, Anđela; Milunović, Vibor; Dreta, Barbara; Franjić, Neven; Coha, Božena; Sinčić-Petričević, Jasminka; Gaćina, Petar; Pejša, Vlatko et al.Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6 doi:10.1097/HS9.0000000000000807 (međunarodna recenzija, članak, znanstveni)
-
5.Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Jonjić, Željko; Mitrović, Zdravko; Prka, Željko; Piršić, Mario; Jakšić, Ozren; Gaćina, Petar et al.Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients // Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82 doi:10.1007/s00508-021-01850-x (međunarodna recenzija, kratko priopcenje, znanstveni)
-
6.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoMore pronounced muscle loss during immunochemotherapy is associated with worse clinical outcomes in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features // Therapeutics and clinical risk management, 17 (2021), 1037-1044 doi:10.2147/tcrm.s323749 (međunarodna recenzija, članak, znanstveni)
-
7.Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Kušec, Rajko; Pejša, VlatkoPerirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients // Hematological oncology, 39 (2021), 4; 575-579 doi:10.1002/hon.2887 (međunarodna recenzija, pismo uredniku, znanstveni)
-
8.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoPrognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type // Leukemia & lymphoma, 62 (2021), 10; 2535-2538 doi:10.1080/10428194.2021.1919667 (međunarodna recenzija, pismo uredniku, znanstveni)
-
9.Bašić-Kinda, Sandra; Hude, Ida; Ranković, Ena; Ostojić-Kolonić, Slobodanka; Pejša, Vlatko; Radman, Ivo; Bogeljić-Patekar, Martina; Jakšić, Ozren; Dubravčić, Klara; Franić-Šimić, Ivana; Aurer, IgorComparison of different schedules of rituximab and chlorambucil in previously untreated chronic lymphocytic leukemia: a retrospective study of Krohem // Journal of cancer science and clinical therapeutics, 5 (2021), 4; 426-433 doi:10.26502/jcsct.5079128 (međunarodna recenzija, članak, znanstveni)
-
10.Lucijanić, Marko; Krečak, Ivan; Galušić, Davor; Sedinić, Martina; Holik Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Štoos- Veić, Tajana; Pejša, Vlatko; Kušec, RajkoHigher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis // Wiener klinische Wochenschrift, 133 (2021), 3-4; 97-103 doi:10.1007/s00508-020-01802-x (međunarodna recenzija, članak, znanstveni)
-
11.Aurer, Igor; Jakšić, Ozren; Basic-Kinda, Sandra; Mišura Jakobac, Karla; Sinčić-Petričević, Jasminka; Novaković Coha, Sabina; Galušić, Davor; Holik, Hrvoje; Valković, Toni; Županić-Krmek, Dubravka et al.Feasibility of obinutuzumab (G) combined with higher doses of chlorambucil (Clb) for frontline treatment of CLL: a retrospective non-interventional study of KroHem, the Croatian Cooperative Group for Hematologic Diseases // XVIII International Workshop on Chronic Lymphocytic Leukemia 2019 / Leukemia & lymphoma, 61(S1)
Edinburgh, Ujedinjeno Kraljevstvo, 2020. str. 111-112 doi:10.1080/10428194.2020.1732667 (poster, međunarodna recenzija, prošireni sažetak, stručni) -
12.Lucijanic, Marko; Galusic, Davor; Soric, Ena; Sedinic, Martina; Cubela, Marta; Huzjan Korunic, Renata; Pejsa, Vlatko; Kusec, RajkoRuxolitinib treatment improves muscle mass in patients with myelofibrosis // Annals of Hematology, 100 (2020), 4; 1105-1106 doi:10.1007/s00277-020-04243-8 (međunarodna recenzija, pismo uredniku, znanstveni)
-
13.Aurer, Igor; Jakšić, Ozren; Bašić-Kinda, Sandra; Mišura Jakobac, Karla; Sinčić- Petričević, Jasminka; Novaković Coha, Sabina; Galušić, Davor; Holik, Hrvoje; Valković, Toni; Županić-Krmek, Dubravka et al.Podnošljivost kombinacija obinutuzumaba i viših doza klorambucila u prvoj liniji liječenja kronične limfocitne leukemije // Bilten Krohema, 12 (2020), 1; 23-23 (podatak o recenziji nije dostupan, članak, stručni)
-
14.Pejsa, Vlatko; Lucijanic, Marko; Vrkljan Vuk, Anamarija; Stoos-Veic, Tajana; Jaksic, Ozren; Jonjic, Željko; Pirsic, Mario; Prka, Željko; Ivic, Marija; Fazlic Dzankic, Amina; Mitrovic , ZdravkoProlonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia // Leukemia & lymphoma, 61 (2020), 4; 934-939 doi:10.1080/10428194.2019.1702182 (međunarodna recenzija, članak, znanstveni)
-
15.Pejša, Vlatko; Jakšić, Branimir; Ostojić Kolonić, Slobodanka; Bašić Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Jakšić, Ozren; Sinčić-Petričević, Jasminka; Gaćina, Petar; Kardum-Skelin, Ika et al.Smjernice za liječenje kronične limfocitne leukemije // Bilten Krohema, 11 (2019), 1; 4-7 (podatak o recenziji nije dostupan, članak, stručni)
-
16.Ledinski Fičko, Sanja; Pejša, Vlatko; Zadnik, VesnaHealth-related Quality of Life in Croatian General Population and Multiple Myeloma Patients Assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 Questionnaires // Radiology and oncology, 53 (2019), 3; 337-347 doi:10.2478/raon-2019-0047 (međunarodna recenzija, članak, znanstveni)
-
17.Radman, Ivo; Vodanović, Marijo; Mandac-Rogulj, Inga; Roganović, Jelena; Petranović, Duška; Valković, Toni; Ostojić Kolonić, Slobodanka; Pejša, Vlatko; Kušec, Rajko; Aurer, IgorSmjernice Hrvatskog društva za hematologiju HLZ-a i KROHEM-a za zbrinjavanje anemije uzrokovane manjkom željeza // Liječnički vjesnik, 141 (2019), 1-2; 1-13 doi:10.26800/lv-141-1-2-1 (recenziran, članak, stručni)
-
18.Lucijanic, Marko; Prka, Zeljko; Pejsa, Vlatko; Stoos-Veic, Tajana; Lucijanic, Jelena; Kusec, RajkoPrognostic implications of low transferrin saturation in patients with primary myelofibrosis // Leukemia Research, 66 (2018), 89-95 doi:10.1016/j.leukres.2018.01.017 (međunarodna recenzija, članak, znanstveni)
-
19.Lucijanic, Marko; Prka, Zeljko; Jaksic, Ozren; Mitrovic, Zdravko; Vrkljan, Anamarija; Pejsa, VlatkoBendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality // American Journal of Hematology, 94 (2018), 2; E42-E43 doi:10.1002/ajh.25340 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
20.Pejsa, Vlatko; Lucijanic, Marko; Jonjic, Zeljko; Prka, Zeljko; Vukorepa, GoranaProgressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia // Annals of Hematology, 98 (2018), 6; 1509-1510 doi:10.1007/s00277-018-3552-x (međunarodna recenzija, pismo uredniku, znanstveni)
-
21.Jakšić, Branimir; Pejša, Vlatko; Ostojić- Kolonić, Slobodanka; Kardum-Skelin, Ika; Bašić-Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Vrhovac, Radovan; Jakšić, Ozren; Aurer, Igor et al.Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017 // Acta clinica Croatica, 57 (2018), 1; 190-215 (recenziran, članak, stručni)
-
22.Lucijanić, Marko; Čičić, David; Štoos‑Veić, Tajana; Pejša, Vlatko; Lucijanić, Jelena; Fazlić Džankić, Amina; VLasac Glasnović, Josipa; Sorić, Ena; Skelin, Marko; Kušec, RajkoElevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? // Anticancer Research, 38 (2018), 5; 3157-3163 doi:10.21873/anticanres.12579 (međunarodna recenzija, članak, znanstveni)
-
23.Jakšić, Branimir; Pejša, Vlatko; Ostojić- Kolonić, Slobodanka; Kardum-Skelin, Ika; Bašić- Kinda, Sandra; Coha, Božena; Gverić- Krečak, Velka; Vrhovac, Radovan; Jakšić, Ozren; Aurer, Igor et al.Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017. // Acta clinica Croatica, 57 (2018), 1; 190-215 doi:10.20471/acc.2018.57.01.27 (međunarodna recenzija, članak, stručni)
-
24.Lucijanić, Marko; Mitrović, Zdravko; Čičić, David; Prka, Željko; Pejša, Vlatko; Livun, Ana; Štoos‑Veić, Tajana; Romić, Željko; Živković, Marcela; Lucijanić, Iva et al.Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis // International journal of hematology, 107 (2018), 2; 166-172 doi:10.1007/s12185-017-2348-4 (podatak o recenziji nije dostupan, članak, znanstveni)
-
25.Lucijanić, Marko; Veletić, Ivo; Rahelić, Dario; Pejša, Vlatko; Čičić, David; Skelin, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Lucijanic, Tomo et al.Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis // Wiener klinische Wochenschrift, 130 (2018), 3/4; 126-133 doi:10.1007/s00508-018-1318-z (međunarodna recenzija, članak, znanstveni)
